Cyclosporine eye gel for dry eye
Part of Eyes & vision clinical trials.
This trial tests a new eye gel that contains cyclosporine (a medicine that lowers inflammation) to see if it helps with dry eye symptoms. If you have long-lasting dry eye, this study might offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have had dry eye symptoms for at least 6 months.
- A doctor must have diagnosed you with dry eye in both eyes.
- Your dry eye symptoms must be moderate to severe (within a certain score range).
- You must not have had any eye surgery in the last 3 months.
- You must be willing to stop using certain eye drops and treatments for the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using special eye drops (cyclosporine) along with tiny plugs placed in the tear ducts can improve dry eye symptoms in people with Sjögren's syndrome. The goal is to see if this combination works better than the drops alone.
This trial tests a medical device eye ointment called Vit-A-Vision for people with dry eye disease. It aims to see if the ointment can improve symptoms and tear film stability over about a month.
This study tests a gel form of cyclosporine for people with moderate to severe dry eye that hasn't improved with other treatments. The gel is applied to the eye to help reduce inflammation and increase tear production.
This trial tests whether an anti-inflammatory eye drop (ciclosporin A) can help dry eyes by changing immune cells on the eye's surface. It lasts 12 weeks and may be an option for people with moderate to severe dry eye.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This study compares two different cyclosporine eye drops to see which one better improves the health of the surface of your eye. One is a newer version (Vevye) and the other is a generic version of Restasis, over 8 weeks of treatment.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.